Literature DB >> 21943720

Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival.

B Ganeshan1, K Skogen, I Pressney, D Coutroubis, K Miles.   

Abstract

AIM: To undertake a pilot study assessing whether tumour heterogeneity evaluated using computed tomography texture analysis (CTTA) has the potential to provide a marker of tumour aggression and prognosis in oesophageal cancer.
MATERIALS AND METHODS: In 21 patients, unenhanced CT images of the primary oesophageal lesion obtained using positron-emission tomography (PET)-CT examinations underwent CTTA. CTTA was carried out using a software algorithm that selectively filters and extracts textures at different anatomical scales between filter values 1.0 (fine detail) and 2.5 (coarse features) with quantification as entropy and uniformity (measures image heterogeneity). Texture parameters were correlated with average tumour 2-[(18)F]-fluoro-2-deoxy-d-glucose (FDG) uptake [standardized uptake values (SUV(mean) and SUV(max))] and clinical staging as determined by endoscopic ultrasound (nodal involvement) and PET-CT (distant metastases). The relationship between tumour stage, FDG uptake, and texture with survival was assessed using Kaplan-Meier analysis.
RESULTS: Tumour heterogeneity correlated with SUV(max) and SUV(mean). The closest correlations were found for SUV(mean) measured as uniformity and entropy with coarse filtration (r=-0.754, p<0.0001; and r=0.748, p=0.0001 respectively). Heterogeneity was also significantly greater in patients with clinical stage III or IV for filter values between 1.0 and 2.0 (maximum difference at filter value 1.5: entropy: p=0.027; uniformity p=0.032). The median (range) survival was 21 (4-34) months. Tumour heterogeneity assessed by CTTA (coarse uniformity) was an independent predictor of survival [odds ratio (OR)=4.45 (95% CI: 1.08, 18.37); p=0.039].
CONCLUSION: CTTA assessment of tumour heterogeneity has the potential to identify oesophageal cancers with adverse biological features and provide a prognostic indicator of survival.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21943720     DOI: 10.1016/j.crad.2011.08.012

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  121 in total

1.  Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.

Authors:  C P Reinert; B Federmann; J Hofmann; H Bösmüller; S Wirths; J Fritz; M Horger
Journal:  Eur Radiol       Date:  2019-06-24       Impact factor: 5.315

2.  Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.

Authors:  Arnaud Hocquelet; Thibaut Auriac; Cynthia Perier; Clarisse Dromain; Marie Meyer; Jean-Baptiste Pinaquy; Alban Denys; Hervé Trillaud; Baudouin Denis De Senneville; Véronique Vendrely
Journal:  Eur Radiol       Date:  2018-02-05       Impact factor: 5.315

3.  Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.

Authors:  Minghui Wu; Hongna Tan; Fei Gao; Jinjin Hai; Peigang Ning; Jian Chen; Shaocheng Zhu; Meiyun Wang; Shewei Dou; Dapeng Shi
Journal:  Eur Radiol       Date:  2018-11-07       Impact factor: 5.315

4.  Computed tomography texture features can discriminate benign from malignant lymphadenopathy in pediatric patients: a preliminary study.

Authors:  Alexis M Cahalane; Aoife Kilcoyne; Azadeh Tabari; Shaunagh McDermott; Michael S Gee
Journal:  Pediatr Radiol       Date:  2019-02-11

5.  CT texture analysis of pancreatic cancer.

Authors:  Kumar Sandrasegaran; Yuning Lin; Michael Asare-Sawiri; Tai Taiyini; Mark Tann
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

Review 6.  The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning.

Authors:  S Alobaidli; S McQuaid; C South; V Prakash; P Evans; A Nisbet
Journal:  Br J Radiol       Date:  2014-07-23       Impact factor: 3.039

Review 7.  Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 2: From Clinical Implementation to Enterprise.

Authors:  Faiq Shaikh; Benjamin Franc; Erastus Allen; Evis Sala; Omer Awan; Kenneth Hendrata; Safwan Halabi; Sohaib Mohiuddin; Sana Malik; Dexter Hadley; Rasu Shrestha
Journal:  J Am Coll Radiol       Date:  2018-02-01       Impact factor: 5.532

8.  Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab.

Authors:  Carole Durot; Sébastien Mulé; Philippe Soyer; Aude Marchal; Florent Grange; Christine Hoeffel
Journal:  Eur Radiol       Date:  2019-01-15       Impact factor: 5.315

9.  Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade.

Authors:  Karoline Skogen; Balaji Ganeshan; Catriona Good; Giles Critchley; Ken Miles
Journal:  J Neurooncol       Date:  2012-12-06       Impact factor: 4.130

Review 10.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.

Authors:  Sugama Chicklore; Vicky Goh; Musib Siddique; Arunabha Roy; Paul K Marsden; Gary J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.